Furthermore, multivariate analysis revealed that elafin-positive cells were independently prognostic of RFS with a HR of 3.0 (P <0.0001) in IHC-defined luminal A-like subtype breast cancer patients (Table 2B). The gene discussed is PI3; the disease is breast cancer.